Content area

|
|

Korrekt brug af hydroxychloroquin medfører sjældent øjenskader

Forfatter(e)

Anne Troldborg1, 2, Trine Bay-Laurberg1, Kåre Clemmensen3, Jeanette Andersen4 & Bent Deleuran1, 2

1) Afdeling for Led- og Bindevævssygdomme, Aarhus Universitetshospital, 2) Institut for Biomedicin, Health, Aarhus Universitet, 3) Klinik for Øjensygdomme, Aarhus Universitetshospital, 4) Lupus Europe, Essex, Storbritannien

Ugeskr Læger 2020;182:V02200115

Reference: 
UgeskrLæger 2020;182:V02200115
Hydroxychloroquine treatment rarely causes eye damage when used correctly

Anne Troldborg, Trine Bay-Laurberg, Kåre Clemmensen, Jeanette Andersen & Bent Deleuran

Ugeskr Læger 2020;182:V02200115

Hydroxychloroquine (HCQ) is used in the treatment of rheumatologic diseases including systemic lupus erythematosus, rheumatoid arthritis and other conditions. Besides reducing joint and skin inflammation, growing evidence shows other beneficial effects of HCQ, e.g. a positive effect on cardiovascular risk, pregnancy outcome, and flare reduction.
In this review, we wish to emphasise "best practice" in the use of HCQ based on the present literature, to show the typical eye damage, which may occur, and to highlight which precautions should be made, so that retinal injury does not occur.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Knud Raben-Pedersen | 21/09
6 kommentarer
af Peter Matzen | 21/09
1 Kommentar
af Finn Vallø Hansen | 21/09
1 Kommentar
af Johan Ludvig Reventlow | 19/09
2 kommentarer
af Andreas Gothardt Lundh | 17/09
1 Kommentar
af Bjørn Søeberg | 17/09
33 kommentarer
af Lene Annette Norberg | 15/09
5 kommentarer
af Søren Holm | 14/09
1 Kommentar